Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Acta Derm Venereol ; 95(5): 565-71, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25366035

RESUMO

The spectrum of skin manifestations of Lyme borreliosis in children is not well characterized. We conducted a retrospective study to analyze the clinical characteristics, seroreactivity to Borrelia burgdorferi sensu lato, and outcome after treatment in 204 children with skin manifestations of Lyme borreliosis seen in 1996-2011. Solitary erythema migrans was the most common manifestation (44.6%), followed by erythema migrans with multiple lesions (27%), borrelial lymphocytoma (21.6%), and acrodermatitis chronica atrophicans (0.9%). A collision lesion of a primary borrelial lymphocytoma and a surrounding secondary erythema migrans was diagnosed in 5.9% of children. Rate of seroreactivity to B. burgdorferi s.l. was lower in solitary erythema migrans compared to other diagnosis groups. Amoxicillin or phenoxymethylpenicillin led to complete resolution of erythema migrans within a median of 6 (solitary) and 14 days (multiple lesions), respectively, and of borrelia lymphocytoma within a median of 56 days. In conclusion, erythema migrans with multiple lesions and borrelial lymphocytoma appear to be more frequent in children than in adults, whereas acrodermatitis chronica atrophicans is a rarity in childhood. The outcome after antibiotic therapy was excellent in children, and appears to be better than in adults.


Assuntos
Acrodermatite/fisiopatologia , Antibacterianos/administração & dosagem , Eritema Migrans Crônico/fisiopatologia , Pseudolinfoma/fisiopatologia , Acrodermatite/tratamento farmacológico , Acrodermatite/etiologia , Administração Oral , Adolescente , Borrelia burgdorferi/isolamento & purificação , Criança , Pré-Escolar , Estudos de Coortes , Quimioterapia Combinada , Eritema Migrans Crônico/tratamento farmacológico , Eritema Migrans Crônico/etiologia , Feminino , Seguimentos , Humanos , Injeções Intravenosas , Doença de Lyme/complicações , Doença de Lyme/diagnóstico , Doença de Lyme/tratamento farmacológico , Masculino , Pseudolinfoma/tratamento farmacológico , Pseudolinfoma/etiologia , Estudos Retrospectivos , Medição de Risco , Índice de Gravidade de Doença , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...